PA-111

DRUG2 trials

Sponsors

Addpharma Inc.

Conditions

Mixed Dyslipidemia

Phase 1

A Study to Compare to PK Characteristics and Safety Profiles Between PA-111 and PA-111A

RecruitingNCT06932705

Addpharma Inc.Mixed Dyslipidemia

Start: 2025-04-30End: 2025-05-31Target: 48Updated: 2025-04-17

The Food Effect on PK Characteristics and Safety Profiles of PA-111

Not yet recruitingNCT06976489

Addpharma Inc.Mixed Dyslipidemia

Start: 2025-05-31End: 2025-07-31Target: 40Updated: 2025-05-16